Valor Management LLC

Institutional investor · Portfolio as of Q2 2026

Q2 2026 biggest moves

Reported value$181M → $86.2B

  • SPCXSPCX

    SpaceX

    New listing

    100% of portfolio

  • THARTHAR

    CANTON STRATEGIC HOLDINGS IN

    Sold out

    was 2.0% of portfolio

3 changes in all

Top Holdings5 positions

Checking export access…
Activity:
SPCX

Space Exploration Technologies Corp.

503.4M$86B99.8%$170.860.00%
1 qtr
New
Unranked
BWAY
BWAY
ADR

BrainsWay Ltd.

5.3M$82.4M0.1%$5.71+171.43%
7 qtrssince 2024-Q4
Unchanged
0
BTGO

BitGo Holdings, Inc.

12.5M$64.9M0.1%$8.23-37.06%
2 qtrssince 2026-Q1
Unchanged
0
HRMY

Harmony Biosciences Holdings, Inc.

818,013$29.8M0.0%$37.30-2.39%
19 qtrssince 2021-Q4
Increased
49
BIOA

BioAge Labs, Inc.

13,105$321,2040.0%$20.80+17.84%
8 qtrssince 2024-Q3
Unchanged
0
$86.2B
AUM
5
Positions
Q2 2026
Filing
HI rating · 1.5/5
Quarterly 13F Value Change
Reported 13F value ($B)
Reported 13F values and quarter-over-quarter reported value changes; not investment returns.
QuarterReported value in US dollarsReported value change
2025-Q1$240,576,897-3.44303701854%
2025-Q2$238,134,281-1.01531611325%
2025-Q3$67,337,124-71.7230447808%
2025-Q4$55,101,559-18.1706082368%
2026-Q1$180,883,163228.2723144%
2026-Q2$86,190,896,51747550.0383383%
Activity profile
$ moved · Q2'26
New>99%Increased<1%Decreased0%Exited<1%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.8 years
<1Q20%1-4Q20%1-2Y20%2Y+40%

Valor Management LLC manages $86.2B across 5 positions as of Q2 2026. Top holdings: SPCX (99.8%), BWAY (0.1%), BTGO (0.1%). Fund DNA: Concentrated Value. HoldingsIntel Score: 1.5/5.0.

Top holdings by portfolio weight

Total AUM$86B
SPCX99.79%
BWAY0.10%
BTGO0.08%
HRMY0.03%
BIOA0.00%
THAR0.00%

Portfolio allocation by GICS sector

Sectors1
Healthcare100.00%

Behavioral investing profile

Checking access…
Concentrated Value
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Below Average(1.5 / 5.0)
Holdings P&L18
Conviction71
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Photo credits

Photo:“Warren Buffett at the 2015 SelectUSA Investment Summit”by USA International Trade Administration, cropped,public domainvia Wikimedia Commons

Photo:Leopold Aschenbrenner

Photo:“Cathie Wood ARK Invest Photo”by Caroline Wood, cropped,CC BY-SA 4.0via Wikimedia Commons

Photo:“Valeant Pharmaceuticals' Business Model (headshot)”by Senate Democrats, cropped,CC BY 2.0via Wikimedia Commons

Photo:Harlem Children's Zone

Photo:Mohnish Pabrai

Photo:“Peter Thiel on March 5 2026”by Kantei (The Prime Minister Office of Japan), cropped,CC BY 4.0via Wikimedia Commons

Photo:Charlotte FC

Photo:Ray Dalio

Photo:Himalaya Capital

Photo:Jonathan Kozowyk, Robin Hood

Photo:“Brad Gerstner at the White House 2025 (54581192563)”by The White House, cropped,public domainvia Wikimedia Commons

Photo:SuperReturn North America

Photo:Liz Linder, Harvard Kennedy School

Photo:Oaktree Capital Management

Photo:The Everglades Foundation

Photo:George Soros

Photo:Benjamin Meaker, Point72

Photo:Fundsmith

Photo:“Kenneth C. Griffin photo”by Paul Elledge, cropped,CC BY-SA 4.0via Wikimedia Commons

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Optional analytics helps us improve. How it’s used